HLA Typing for Transplant Market - By Technology (Non-Molecular Assays, Molecular Assays), By Product And Services (Instruments, Reagents And Consumables, Software, Services), By Application (Diagnostics, Research), By End-Use & Forecast, 2023-2032

Report ID: GMI1653
   |
Published Date: November 2022
 | 
Report Format: PDF

Download Free PDF

HLA Typing for Transplant Market Size

HLA Typing for Transplant Market size was worth more than USD 735 million in 2022 and is projected to expand at over 8.5% CAGR from 2023-2032.
 

Increasing frequency of solid organ transplant procedures will have a positive impact on the HLA typing for transplant industry dynamics. HLA typing or human leukocyte antigen typing is used to match donors and recipients during bone marrow or cord blood transplants. Rising incidences of diseases necessitating bone marrow transplants such as lymphomas, multiple myeloma, leukemia, and immune deficiency disorders, will propel the need for HLA typing.
 

HLA Typing for Transplant Market

A shortage of donors could restrain the market expansion. The presence of a substantial gap between the number of organs required and the organs donated is a major challenge for the healthcare community. Despite advances in medical technology and rigorous campaigns promoting the need for organ donors, there exists a considerable disparity between supply and demand.
 

 

HLA Typing for Transplant Market Analysis

HLA typing for transplant market from molecular assays technology is anticipated to exceed USD 1.5 billion by 2032. Hospitals, laboratories, and medical centers are rapidly shifting toward molecular assay technology for next-generation sequencing (NGS) in tissue typing. It offers end-users high-throughput, efficient, and DNA sequencers in HLA testing. The growing use of technologies such as NGS, PCR, and RT-PCR in healthcare will further proliferate the use of molecular assay techniques.
 

HLA Typing for Transplant Market Share, By Product & Services

In terms of revenue share, the software segment of the HLA typing for transplant market is estimated to reach USD 250 million by 2032. Software assistance in HLA typing is gaining momentum as the process is time-consuming. Technological advancements have enabled the development of sophisticated software to analyze and compile data through HLA typing. Several industry players are introducing novel software to enhance the efficiency of organ transplant procedures.
 

HLA typing for transplant market from diagnostic labs is projected to surpass USD 943 million by 2032. Over the last few years, the number of HLA testing procedures performed at diagnostic laboratories has increased substantially on account of the increasing frequency of organ transplants. According to the Global Observatory on Donation & Transplantation, approximately 129,681 organ transplant surgeries were performed in 2020. The rising prevalence of genetic conditions, chronic disorders, and physical injuries will fuel the need for HLA typing at diagnostic labs.
 

HLA Typing for Transplant Market Size, By Region

North America HLA typing for transplant market was more than 35% in 2022. Developed countries like the U.S and Canada with robust healthcare infrastructure and expenditure will positively influence the regional industry landscape. Several government initiatives have been implemented to ensure the ethical execution of organ donation processes along with transplantation programs. These countries have also reported considerable growth in the demand for organ transplants in recent years.
 

HLA Typing for Transplant Market Share

Some of the leading companies in the HLA typing for transplant market are

  • Luminex Corporation
  • Pacific Biosciences of California, Inc
  • Abbott Laboratories
  • Bio-Rad Laboratories
  • BioReference Laboratories
  • CareDx, Inc.
  • GenDx
  • Illumina Inc.
  • Fujirebio
  • BAG Diagnostic GmbH
  • Immucor Inc.
  • Inno-train Diagnostik GmbH
  • Omixon, Inc.
  • Qiagen N.V.
  • F. Hoffmann-La Roche Ltd
  • Thermo-Fisher Scientific Inc.
  • GMSbiotech, Inc.
  • Biofortuna Limited
  • TBG Diagnostics Limited
     

Impact of COVID-19 Pandemic

The COVID-19 pandemic resulted in a negative impact on the HLA typing for transplant industry. Owing to the dramatically surging number of COVID-19 infections, a large number of healthcare facilities delayed or postponed non-essential surgical procedures such as organ transplants and non-invasive procedures. As a result, the need for HLA typing and sequencing systems was reduced significantly. However, the emergence of new healthcare trends and a growing preference for at-home care encouraged the development of innovative testing products enabling accurate diagnosis at home.
 

Global HLA typing for transplant market research report includes in-depth coverage of the industry with estimates & forecasts in terms of volume in Kilo Tons and revenue in USD Billion from 2018 to 2032 for the following segments:

Market Size, By Technology

  • Non-Molecular Assays
    • Serological Assays
    • Mixed Lymphocyte Culture Assays
  • Molecular Assays
    • PCR Based Molecular Assays
    • Sequencing Based Molecular Assays
      • Sanger Sequencing
      • Next Generation Sequencing

Market Size, By Products & Services

  • Instruments
  • Reagents and Consumables
  • Software
  • Services

Market Size, By Application

  • Diagnostics
  • Research

Market Size, By Application

  • Hospitals
  • Diagnostic Labs
  • Academic and Research Institutes

The above information is provided for the following regions and countries:

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Russia
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
  • Latin America
    • Brazil
    • Mexico
  • Middle East & Africa
    • South Africa
    • Saudi Arabia

 

Authors: Mariam Faizullabhoy, Gauri Wani
HLA Typing for Transplant Market Scope
  • HLA Typing for Transplant Market Size
  • HLA Typing for Transplant Market Trends
  • HLA Typing for Transplant Market Analysis
  • HLA Typing for Transplant Market Share

Report Content

Chapter 1   Methodology

1.1    Market definitions

1.2    Base estimates & working

1.2.1    North America

1.2.2    Europe

1.2.3    Asia Pacific

1.2.4    Latin America

1.2.5    Middle East & Africa

1.3    Forecast parameters

1.4    Data validation

1.5    Data sources

1.5.1    Secondary

1.5.1.1    Paid Sources

1.5.1.2    Unpaid Sources

1.5.2    Primary

Chapter 2   Executive Summary

2.1    HLA typing for transplant industry 3600 synopsis, 2018 - 2032

2.2    Business trends

2.2.1    Technology trends

2.2.2    Product and services trends

2.2.3    Application trends

2.2.4    End-use trends

2.2.5    Regional trends

Chapter 3   HLA Typing for Transplant Industry Insights

3.1    Industry segmentation

3.2    Industry landscape, 2018 - 2032 (USD Million)

3.3    Industry impact forces

3.3.1    Growth drivers

3.3.1.1    Increasing number of solid organ transplants

3.3.1.2    Technological advancements

3.3.1.3    Increasing geriatric population

3.3.2    Restraints

3.3.2.1    Significant gap between number of organs donated and organs required

3.3.2.2    High cost of molecular tests

3.4    Growth potential analysis

3.4.1    By technology

3.4.2    By product and services

3.4.3    By application

3.4.4    By end-use

3.5    COVID-19 impact analysis

3.6    Total number of HLA typing test performed annually, by region, 2017-2021 (000’ Units)

3.7    Pricing analysis, 2021

3.8    In-house lab-based HLA typing test v/s kits from diagnostic manufacturer

3.9    Evolution of different HLA typing method

3.9.1    PCR-based testing method

3.9.2    NGS-based testing method

3.10    Regulatory landscape

3.10.1    U.S.

3.10.2    Europe

3.11    Porter's analysis

3.11.1    Bargaining power of buyers

3.11.2    Bargaining power of suppliers

3.11.3    Threat of new entrants

3.11.4    Threat of substitutes

3.11.5    Industry rivalry

3.12    PESTEL analysis

3.12.1    Political

3.12.1    Economic

3.12.1    Social

3.12.1    Technological

3.12.1    Environmental

3.12.2    Legal

Chapter 4   Competition Landscape, 2022

4.1    Introduction

4.2    Company market share analysis, 2022

4.3    Company matrix analysis, 2022

4.4    Strategy dashboard, 2022

Chapter 5   HLA Typing for Transplant Market, By Technology

5.1    Key segment trends

5.2    Non-molecular assays

5.2.1    Market size, by region, 2018-2032 (USD Million)

5.2.2    Serological assays

5.2.2.1    Market size, by region, 2018-2032 (USD Million)

5.2.3    Mixed lymphocyte culture assays

5.2.3.1    Market size, by region, 2018-2032 (USD Million)

5.3    Molecular assays

5.3.1    Market size, by region, 2018-2032 (USD Million)

5.3.2    PCR based molecular assays

5.3.2.1    Market size, by region, 2018-2032 (USD Million)

5.3.3    Sequencing based molecular assays

5.3.3.1    Market size, by region, 2018-2032 (USD Million)

5.3.3.2    Sanger sequencing

5.3.3.2.1    Market size, by region, 2018-2032 (USD Million)

5.3.3.3    Next generation sequencing

5.3.3.3.1    Market size, by region, 2018-2032 (USD Million)

Chapter 6   HLA Typing for Transplant Market, By Product & Services

6.1    Key segment trends

6.2    Instruments

6.2.1    Market size, by region, 2018-2032 (USD Million)

6.3    Reagents and consumables

6.3.1    Market size, by region, 2018-2032 (USD Million)

6.4    Software

6.4.1    Market size, by region, 2018-2032 (USD Million)

6.5    Services

6.5.1    Market size, by region, 2018-2032 (USD Million)

Chapter 7   HLA Typing for Transplant Market, By Application

7.1    Key segment trends

7.2    Diagnostics

7.2.1    Market size, by region, 2018-2032 (USD Million)

7.3    Research

7.3.1    Market size, by region, 2018-2032 (USD Million)

Chapter 8   HLA Typing for Transplant Market, By End-use

8.1    Key segment trends

8.2    Hospitals

8.2.1    Market size, by region, 2018-2032 (USD Million)

8.3    Diagnostic labs

8.3.1    Market size, by region, 2018-2032 (USD Million)

8.4    Academic and research institutes centers

8.4.1    Market size, by region, 2018-2032 (USD Million)

Chapter 9   HLA Typing for Transplant Market, By Region

9.1    Key regional trends

9.2    North America

9.2.1    Market size, by country, 2018-2032 (USD Million)

9.2.2    Market size, by technology, 2018-2032 (USD Million)

9.2.2.1    Market size, by non-molecular assays, 2018-2032 (USD Million)

9.2.2.2    Market size, by molecular assays, 2018-2032 (USD Million)

9.2.2.2.1    Market size, by sequencing based molecular assays, 2018-2032 (USD Million)

9.2.3    Market size, by product and services, 2018-2032 (USD Million)

9.2.4    Market size, by application, 2018-2032 (USD Million)

9.2.5    Market size, by end-use, 2018-2032 (USD Million)

9.2.6    U.S.

9.2.6.1    Market size, by technology, 2018-2032 (USD Million)

9.2.6.1.1    Market size, by non-molecular assays, 2018-2032 (USD Million)

9.2.6.1.2    Market size, by molecular assays, 2018-2032 (USD Million)

9.2.6.1.2.1    Market size, by sequencing based molecular assays, 2018-2032 (USD Million)

9.2.6.2    Market size, by product and services, 2018-2032 (USD Million)

9.2.6.3    Market size, by application, 2018-2032 (USD Million)

9.2.6.4    Market size, by end-use, 2018-2032 (USD Million)

9.2.7    Canada

9.2.7.1    Market size, by technology, 2018-2032 (USD Million)

9.2.7.1.1    Market size, by non-molecular assays, 2018-2032 (USD Million)

9.2.7.1.2    Market size, by molecular assays, 2018-2032 (USD Million)

9.2.7.1.2.1    Market size, by sequencing based molecular assays, 2018-2032 (USD Million)

9.2.7.2    Market size, by product and services, 2018-2032 (USD Million)

9.2.7.3    Market size, by application, 2018-2032 (USD Million)

9.2.7.4    Market size, by end-use, 2018-2032 (USD Million)

9.3    Europe

9.3.1    Market size, by country, 2018-2032 (USD Million)

9.3.2    Market size, by technology, 2018-2032 (USD Million)

9.3.2.1    Market size, by non-molecular assays, 2018-2032 (USD Million)

9.3.2.2    Market size, by molecular assays, 2018-2032 (USD Million)

9.3.2.2.1    Market size, by sequencing based molecular assays, 2018-2032 (USD Million)

9.3.3    Market size, by product and services, 2018-2032 (USD Million)

9.3.4    Market size, by application, 2018-2032 (USD Million)

9.3.5    Market size, by end-use, 2018-2032 (USD Million)

9.3.6    Germany

9.3.6.1    Market size, by technology, 2018-2032 (USD Million)

9.3.6.1.1    Market size, by non-molecular assays, 2018-2032 (USD Million)

9.3.6.1.2    Market size, by molecular assays, 2018-2032 (USD Million)

9.3.6.1.2.1    Market size, by sequencing based molecular assays, 2018-2032 (USD Million)

9.3.6.2    Market size, by product and services, 2018-2032 (USD Million)

9.3.6.3    Market size, by application, 2018-2032 (USD Million)

9.3.6.4    Market size, by end-use, 2018-2032 (USD Million)

9.3.7    UK

9.3.7.1    Market size, by technology, 2018-2032 (USD Million)

9.3.7.1.1    Market size, by non-molecular assays, 2018-2032 (USD Million)

9.3.7.1.2    Market size, by molecular assays, 2018-2032 (USD Million)

9.3.7.1.2.1    Market size, by sequencing based molecular assays, 2018-2032 (USD Million)

9.3.7.2    Market size, by product and services, 2018-2032 (USD Million)

9.3.7.3    Market size, by application, 2018-2032 (USD Million)

9.3.7.4    Market size, by end-use, 2018-2032 (USD Million)

9.3.8    France

9.3.8.1    Market size, by technology, 2018-2032 (USD Million)

9.3.8.1.1    Market size, by non-molecular assays, 2018-2032 (USD Million)

9.3.8.1.2    Market size, by molecular assays, 2018-2032 (USD Million)

9.3.8.1.2.1    Market size, by sequencing based molecular assays, 2018-2032 (USD Million)

9.3.8.2    Market size, by product and services, 2018-2032 (USD Million)

9.3.8.3    Market size, by application, 2018-2032 (USD Million)

9.3.8.4    Market size, by end-use, 2018-2032 (USD Million)

9.3.9    Italy

9.3.9.1    Market size, by technology, 2018-2032 (USD Million)

9.3.9.1.1    Market size, by non-molecular assays, 2018-2032 (USD Million)

9.3.9.1.2    Market size, by molecular assays, 2018-2032 (USD Million)

9.3.9.1.2.1    Market size, by sequencing based molecular assays, 2018-2032 (USD Million)

9.3.9.2    Market size, by product and services, 2018-2032 (USD Million)

9.3.9.3    Market size, by application, 2018-2032 (USD Million)

9.3.9.4    Market size, by end-use, 2018-2032 (USD Million)

9.3.10    Spain

9.3.10.1    Market size, by technology, 2018-2032 (USD Million)

9.3.10.1.1    Market size, by non-molecular assays, 2018-2032 (USD Million)

9.3.10.1.2    Market size, by molecular assays, 2018-2032 (USD Million)

9.3.10.1.2.1    Market size, by sequencing based molecular assays, 2018-2032 (USD Million)

9.3.10.2    Market size, by product and services, 2018-2032 (USD Million)

9.3.10.3    Market size, by application, 2018-2032 (USD Million)

9.3.10.4    Market size, by end-use, 2018-2032 (USD Million)

9.3.11    Russia

9.3.11.1    Market size, by technology, 2018-2032 (USD Million)

9.3.11.1.1    Market size, by non-molecular assays, 2018-2032 (USD Million)

9.3.11.1.2    Market size, by molecular assays, 2018-2032 (USD Million)

9.3.11.1.2.1    Market size, by sequencing based molecular assays, 2018-2032 (USD Million)

9.3.11.2    Market size, by product and services, 2018-2032 (USD Million)

9.3.11.3    Market size, by application, 2018-2032 (USD Million)

9.3.11.4    Market size, by end-use, 2018-2032 (USD Million)

9.4    Asia Pacific

9.4.1    Market size, by country, 2018-2032 (USD Million)

9.4.2    Market size, by technology, 2018-2032 (USD Million)

9.4.2.1    Market size, by non-molecular assays, 2018-2032 (USD Million)

9.4.2.2    Market size, by molecular assays, 2018-2032 (USD Million)

9.4.2.2.1    Market size, by sequencing based molecular assays, 2018-2032 (USD Million)

9.4.3    Market size, by product and services, 2018-2032 (USD Million)

9.4.4    Market size, by application, 2018-2032 (USD Million)

9.4.5    Market size, by end-use, 2018-2032 (USD Million)

9.4.6    China

9.4.6.1    Market size, by technology, 2018-2032 (USD Million)

9.4.6.1.1    Market size, by non-molecular assays, 2018-2032 (USD Million)

9.4.6.1.2    Market size, by molecular assays, 2018-2032 (USD Million)

9.4.6.1.2.1    Market size, by sequencing based molecular assays, 2018-2032 (USD Million)

9.4.6.2    Market size, by product and services, 2018-2032 (USD Million)

9.4.6.3    Market size, by application, 2018-2032 (USD Million)

9.4.6.4    Market size, by end-use, 2018-2032 (USD Million)

9.4.7    India

9.4.7.1    Market size, by technology, 2018-2032 (USD Million)

9.4.7.1.1    Market size, by non-molecular assays, 2018-2032 (USD Million)

9.4.7.1.2    Market size, by molecular assays, 2018-2032 (USD Million)

9.4.7.1.2.1    Market size, by sequencing based molecular assays, 2018-2032 (USD Million)

9.4.7.2    Market size, by product and services, 2018-2032 (USD Million)

9.4.7.3    Market size, by application, 2018-2032 (USD Million)

9.4.7.4    Market size, by end-use, 2018-2032 (USD Million)

9.4.8    Japan

9.4.8.1    Market size, by technology, 2018-2032 (USD Million)

9.4.8.1.1    Market size, by non-molecular assays, 2018-2032 (USD Million)

9.4.8.1.2    Market size, by molecular assays, 2018-2032 (USD Million)

9.4.8.1.2.1    Market size, by sequencing based molecular assays, 2018-2032 (USD Million)

9.4.8.2    Market size, by product and services, 2018-2032 (USD Million)

9.4.8.3    Market size, by application, 2018-2032 (USD Million)

9.4.8.4    Market size, by end-use, 2018-2032 (USD Million)

9.4.9    Australia

9.4.9.1    Market size, by technology, 2018-2032 (USD Million)

9.4.9.1.1    Market size, by non-molecular assays, 2018-2032 (USD Million)

9.4.9.1.2    Market size, by molecular assays, 2018-2032 (USD Million)

9.4.9.1.2.1    Market size, by sequencing based molecular assays, 2018-2032 (USD Million)

9.4.9.2    Market size, by product and services, 2018-2032 (USD Million)

9.4.9.3    Market size, by application, 2018-2032 (USD Million)

9.4.9.4    Market size, by end-use, 2018-2032 (USD Million)

9.5    Latin America

9.5.1    Market size, by country, 2018-2032 (USD Million)

9.5.2    Market size, by technology, 2018-2032 (USD Million)

9.5.2.1    Market size, by non-molecular assays, 2018-2032 (USD Million)

9.5.2.2    Market size, by molecular assays, 2018-2032 (USD Million)

9.5.2.2.1    Market size, by sequencing based molecular assays, 2018-2032 (USD Million)

9.5.3    Market size, by product and services, 2018-2032 (USD Million)

9.5.4    Market size, by application, 2018-2032 (USD Million)

9.5.5    Market size, by end-use, 2018-2032 (USD Million)

9.5.6    Brazil

9.5.6.1    Market size, by technology, 2018-2032 (USD Million)

9.5.6.1.1    Market size, by non-molecular assays, 2018-2032 (USD Million)

9.5.6.1.2    Market size, by molecular assays, 2018-2032 (USD Million)

9.5.6.1.2.1    Market size, by sequencing based molecular assays, 2018-2032 (USD Million)

9.5.6.2    Market size, by product and services, 2018-2032 (USD Million)

9.5.6.3    Market size, by application, 2018-2032 (USD Million)

9.5.6.4    Market size, by end-use, 2018-2032 (USD Million)

9.5.7    Mexico

9.5.7.1    Market size, by technology, 2018-2032 (USD Million)

9.5.7.1.1    Market size, by non-molecular assays, 2018-2032 (USD Million)

9.5.7.1.2    Market size, by molecular assays, 2018-2032 (USD Million)

9.5.7.1.2.1    Market size, by sequencing based molecular assays, 2018-2032 (USD Million)

9.5.7.2    Market size, by product and services, 2018-2032 (USD Million)

9.5.7.3    Market size, by application, 2018-2032 (USD Million)

9.5.7.4    Market size, by end-use, 2018-2032 (USD Million)

9.6    MEA

9.6.1    Market size, by country, 2018-2032 (USD Million)

9.6.2    Market size, by technology, 2018-2032 (USD Million)

9.6.2.1    Market size, by non-molecular assays, 2018-2032 (USD Million)

9.6.2.2    Market size, by molecular assays, 2018-2032 (USD Million)

9.6.2.2.1    Market size, by sequencing based molecular assays, 2018-2032 (USD Million)

9.6.3    Market size, by product and services, 2018-2032 (USD Million)

9.6.4    Market size, by application, 2018-2032 (USD Million)

9.6.5    Market size, by end-use, 2018-2032 (USD Million)

9.6.6    South Africa

9.6.6.1    Market size, by technology, 2018-2032 (USD Million)

9.6.6.1.1    Market size, by non-molecular assays, 2018-2032 (USD Million)

9.6.6.1.2    Market size, by molecular assays, 2018-2032 (USD Million)

9.6.6.1.2.1    Market size, by sequencing based molecular assays, 2018-2032 (USD Million)

9.6.6.2    Market size, by product and services, 2018-2032 (USD Million)

9.6.6.3    Market size, by application, 2018-2032 (USD Million)

9.6.6.4    Market size, by end-use, 2018-2032 (USD Million)

9.6.7    Saudi Arabia

9.6.7.1    Market size, by technology, 2018-2032 (USD Million)

9.6.7.1.1    Market size, by non-molecular assays, 2018-2032 (USD Million)

9.6.7.1.2    Market size, by molecular assays, 2018-2032 (USD Million)

9.6.7.1.2.1    Market size, by sequencing based molecular assays, 2018-2032 (USD Million)

9.6.7.2    Market size, by product and services, 2018-2032 (USD Million)

9.6.7.3    Market size, by application, 2018-2032 (USD Million)

9.6.7.4    Market size, by end-use, 2018-2032 (USD Million)

Chapter 10   Company Profiles

10.1    Abbott Laboratories

10.1.1    Business overview

10.1.2    Financial data

10.1.3    Product landscape

10.1.4    Strategic outlook

10.1.5    SWOT analysis

10.2    Bio-Rad Laboratories

10.2.1    Business overview

10.2.2    Financial data

10.2.3    Product landscape

10.2.4    Strategic outlook

10.2.5    SWOT analysis

10.3    BioReference Laboratories

10.3.1    Business overview

10.3.2    Financial data

10.3.3    Product landscape

10.3.4    SWOT analysis

10.4    CareDx, Inc.

10.4.1    Business overview

10.4.2    Financial data

10.4.3    Product landscape

10.4.4    Strategic outlook

10.4.5    SWOT analysis

10.5    GenDx

10.5.1    Business overview

10.5.2    Financial data

10.5.3    Product landscape

10.5.4    Strategic outlook

10.5.5    SWOT analysis

10.6    Illumina Inc.

10.6.1    Business overview

10.6.2    Financial data

10.6.3    Product landscape

10.6.4    Strategic outlook

10.6.5    SWOT analysis

10.7    Immucor Inc.

10.7.1    Business overview

10.7.2    Financial data

10.7.3    Product landscape

10.7.4    Strategic outlook

10.7.5    SWOT analysis

10.8    Inno-train Diagnostik GmbH

10.8.1    Business overview

10.8.2    Financial data

10.8.3    Product landscape

10.8.4    SWOT analysis

10.9    Luminex Corporation

10.9.1    Business overview

10.9.2    Financial data

10.9.3    Product landscape

10.9.4    SWOT analysis

10.10    Omixon, Inc

10.10.1   Business overview

10.10.2   Financial data

10.10.3   Product landscape

10.10.4   Strategic outlook

10.10.5   SWOT analysis

10.11    Pacific Biosciences of California, Inc

10.11.1   Business overview

10.11.2   Financial data

10.11.3   Product landscape

10.11.4   Strategic outlook

10.11.5   SWOT analysis

10.12    Qiagen N.V.

10.12.1   Business overview

10.12.2   Financial data

10.12.3   Product landscape

10.12.4   SWOT analysis

10.13    F. Hoffmann-La Roche Ltd

10.13.1   Business overview

10.13.2   Financial data

10.13.3   Product landscape

10.13.4   SWOT analysis

10.14    Thermo-Fisher Scientific Inc.

10.14.1   Business overview

10.14.2   Financial data

10.14.3   Product landscape

10.14.4   Strategic outlook

10.14.5   SWOT analysis

10.15    Fujirebio

10.15.1   Business overview

10.15.2   Financial data

10.15.3   Product landscape

10.15.4   SWOT analysis

10.16    BAG Diagnostic GmbH

10.16.1   Business overview

10.16.2   Financial data

10.16.3   Product landscape

10.16.4   SWOT analysis

10.17    GMSbiotech, Inc.

10.17.1   Business overview

10.17.2   Financial data

10.17.3   Product landscape

10.17.4   SWOT analysis

10.18    Biofortuna Limited

10.18.1   Business overview

10.18.2   Financial data

10.18.3   Product landscape

10.18.4   Strategic outlook

10.18.5   SWOT analysis

10.19    TBG Diagnostics Limited

10.19.1   Business overview

10.19.2   Financial data

10.19.3   Product landscape

10.19.4   Strategic outlook

10.19.5   SWOT analysis

Authors: Mariam Faizullabhoy, Gauri Wani
Immediate Delivery
Trust Factor 1
Trust Factor 2
Trust Factor 1
Premium Report Details

Base Year: 2022

Companies covered: 19

Tables & Figures: 372

Countries covered: 15

Pages: 255

Download Free PDF

img

HLA Typing for Transplant Market

Get a free sample of this report
country Flag
+1
img
Get a free sample of this report HLA Typing for Transplant Market
Is your requirement urgent? Please give us your business email for a speedy delivery!
Your personal details will remain secure and confidential.

Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!

Top
Global Market Insights Inc.
ISO Certificate
PCI ASV COMPLIANT
Authorize.Net
Accredited Business
DMCA
vikingcloud

Industries

Information

Link

Global Headquarters

Global Market Insights Inc. 4 North Main Street, Selbyville, Delaware 19975 USA
Toll free : +1-888-689-0688
USA : +1-302-846-7766
APAC : +65-3129-7718
Email: sales@gminsights.com
Global Market Insights Inc. © 2025 All Rights Reserved.
We use cookies to enhance user experience. (Privacy Policy)